These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 11919662

  • 1. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.
    Bymaster FP, Zhang W, Carter PA, Shaw J, Chernet E, Phebus L, Wong DT, Perry KW.
    Psychopharmacology (Berl); 2002 Apr; 160(4):353-61. PubMed ID: 11919662
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study.
    Koch S, Perry KW, Nelson DL, Conway RG, Threlkeld PG, Bymaster FP.
    Neuropsychopharmacology; 2002 Dec; 27(6):949-59. PubMed ID: 12464452
    [Abstract] [Full Text] [Related]

  • 4. Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex.
    Amargós-Bosch M, Artigas F, Adell A.
    Eur J Pharmacol; 2005 Jun 15; 516(3):235-8. PubMed ID: 15967429
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
    Beyer CE, Boikess S, Luo B, Dawson LA.
    J Psychopharmacol; 2002 Dec 15; 16(4):297-304. PubMed ID: 12503828
    [Abstract] [Full Text] [Related]

  • 7. Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.
    Li SX, Perry KW, Wong DT.
    Neuropharmacology; 2002 Feb 15; 42(2):181-90. PubMed ID: 11804614
    [Abstract] [Full Text] [Related]

  • 8. Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram.
    Pozzi L, Invernizzi R, Garavaglia C, Samanin R.
    J Neurochem; 1999 Sep 15; 73(3):1051-7. PubMed ID: 10461894
    [Abstract] [Full Text] [Related]

  • 9. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine.
    Jordan S, Kramer GL, Zukas PK, Moeller M, Petty F.
    Synapse; 1994 Dec 15; 18(4):294-7. PubMed ID: 7886621
    [Abstract] [Full Text] [Related]

  • 10. Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats.
    Perry KW, Fuller RW.
    J Neural Transm (Vienna); 1997 Dec 15; 104(8-9):953-66. PubMed ID: 9451727
    [Abstract] [Full Text] [Related]

  • 11. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine.
    Li XM, Perry KW, Wong DT.
    Chin J Physiol; 1999 Jun 30; 42(2):53-9. PubMed ID: 10513599
    [Abstract] [Full Text] [Related]

  • 12. Effect of paroxetine on extracellular serotonin and dopamine levels in the prefrontal cortex.
    Nakayama K.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb 30; 365(2):102-5. PubMed ID: 11819027
    [Abstract] [Full Text] [Related]

  • 13. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
    Dawson LA, Li P.
    J Neural Transm (Vienna); 2003 Jun 30; 110(6):577-90. PubMed ID: 12768354
    [Abstract] [Full Text] [Related]

  • 14. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
    Koch S, Hemrick-Luecke SK, Thompson LK, Evans DC, Threlkeld PG, Nelson DL, Perry KW, Bymaster FP.
    Neuropharmacology; 2003 Dec 30; 45(7):935-44. PubMed ID: 14573386
    [Abstract] [Full Text] [Related]

  • 15. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P, Kehr J, Scheel-Krüger J.
    J Psychopharmacol; 2007 Nov 30; 21(8):795-804. PubMed ID: 17984160
    [Abstract] [Full Text] [Related]

  • 16. Effect of risperidone on the fluoxetine-induced changes in extracellular dopamine, serotonin and noradrenaline in the rat frontal cortex.
    Kamińska K, Gołembiowska K, Rogóż Z.
    Pharmacol Rep; 2013 Nov 30; 65(5):1144-51. PubMed ID: 24399710
    [Abstract] [Full Text] [Related]

  • 17. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex.
    Felton TM, Kang TB, Hjorth S, Auerbach SB.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar 30; 367(3):297-305. PubMed ID: 12644903
    [Abstract] [Full Text] [Related]

  • 18. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
    Rollema H, Wilson GG, Lee TC, Folgering JH, Flik G.
    Neurochem Int; 2011 Jan 30; 58(1):78-84. PubMed ID: 21056607
    [Abstract] [Full Text] [Related]

  • 19. Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex.
    Sakaue M, Somboonthum P, Nishihara B, Koyama Y, Hashimoto H, Baba A, Matsuda T.
    Br J Pharmacol; 2000 Mar 30; 129(5):1028-34. PubMed ID: 10696105
    [Abstract] [Full Text] [Related]

  • 20. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T, Umbers V, Gartside SE.
    Br J Pharmacol; 1997 Jul 30; 121(5):941-6. PubMed ID: 9222551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.